SCHEMBL32665508

SCHEMBL32665508

O=C1C=CC(=O)N1C1CC2(CCN(Cc3cccc(OS(=O)(=O)F)c3)CC2)C1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CCR8 P51685 4/20 0.39
KCNH2 Q12809 4/20 0.39
CXCR3 P49682 2/20 0.38
MMP1 P03956 1/20 0.38
MMP9 P14780 1/20 0.38
MMP13 P45452 1/20 0.38
ADAM17 P78536 1/20 0.38
OPRM1 P35372 3/20 0.37
FAAH O00519 2/20 0.37
SIGMAR1 Q99720 2/20 0.37
CHRM2 P08172 2/20 0.37
CACNA1F O60840 1/20 0.37
ADRB1 P08588 1/20 0.37
DRD2 P14416 1/20 0.37
SLC6A2 P23975 1/20 0.37
ADRA1D P25100 1/20 0.37
ADRA1A P35348 1/20 0.37
HRH1 P35367 1/20 0.37
ADRA1B P35368 1/20 0.37
DRD3 P35462 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL32665137 0.87 HRH3 (0.36) CXCR3MMP1MMP9MMP13ADAM17
SCHEMBL32665569 0.86 OPRM1 (0.44) OPRM1CHRM2DRD2ALDH1A1CHRM3
SCHEMBL32665061 0.86 KCNH2 (0.38) CCR8KCNH2CXCR3MMP1MMP9
SCHEMBL32665454 0.83 FFAR4 (0.38) SLC6A2SLC6A3ALDH1A1USP2CYP3A4
SCHEMBL32665432 0.83 NPSR1 (0.36) KCNH2SIGMAR1CHRM2DRD2HRH1
SCHEMBL32665089 0.83 DOCK5 (0.35) CXCR3SIGMAR1DRD3ALDH1A1MAPK1
Formic Acid SCHEMBL32665547 0.82 OPRM1 (0.41) CCR8OPRM1FAAHCHRM2DRD2
SCHEMBL32665228 0.79 CHRM2 (0.46) OPRM1SIGMAR1CHRM2DRD2DRD3
SCHEMBL32665186 0.79 MAPK1 (0.41) ALDH1A1USP2CYP3A4CYP2D6MAPK1
SCHEMBL32665507 0.73 MGLL (0.49) FAAHALDH1A1MAPK1ALDH3A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260021192-A1 PROTEINS HAVING A COVALENT WARHEAD TOPAZ THERAPEUTICS INC (US) 2026-01-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260021192-A1 PROTEINS HAVING A COVALENT WARHEAD RIOX2, ORC3, DCLRE1A CCR8 1123/4885KCNH2 4668/4885CXCR3 1374/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.